Literature DB >> 25289881

Etiology and management of recurrent parotid pleomorphic adenoma.

Robert L Witt1, David W Eisele, Randall P Morton, Piero Nicolai, Vincent Vander Poorten, Peter Zbären.   

Abstract

The objective of this review study was to encompass the relevant literature and current best practice options for this challenging, sometimes incurable problem. The source of the data was Ovid MEDLINE from 1946 to 2014. Review methods consisted of articles with clinical correlates. The most important cause of recurrence is enucleation with rupture and incomplete tumor excision at operation. Incomplete pseudocapsule, extracapsular extension, pseudopods of pleomorphic adenoma tissue, and satellite pleomorphic beyond the pseudocapsule are also likely linked to recurrent pleomorphic adenoma. Most recurrent pleomorphic adenoma are multinodular. Magnetic resonance imaging is the imaging study of choice for recurrent pleomorphic adenoma. Nerve integrity monitoring may reduce morbidity for recurrent pleomorphic adenoma. Treatment of recurrent pleomorphic adenoma must be individualized. Total parotidectomy, given the multicentricity of recurrent pleomorphic adenoma, is appropriate in many patients, but may be inadequate to control recurrent pleomorphic. There is accumulating evidence from retrospective series that postoperative radiation therapy results in significantly better local control.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  benign mixed tumor; etiology; management; pleomorphic adenoma; recurrence

Mesh:

Year:  2014        PMID: 25289881     DOI: 10.1002/lary.24964

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  22 in total

Review 1.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

Review 2.  Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors.

Authors:  Georgios Psychogios; Christopher Bohr; Jannis Constantinidis; Martin Canis; Vincent Vander Poorten; Jan Plzak; Andreas Knopf; Christian Betz; Orlando Guntinas-Lichius; Johannes Zenk
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

3.  The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.

Authors:  Laura Mc Loughlin; Sarah Louise Gillanders; Susan Smith; Orla Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-13       Impact factor: 2.503

4.  Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.

Authors:  Timo Atula; Jaana Hagström; Anttoni Markkanen; Katri Aro; Anna Ray Laury; Antti A Mäkitie; Caj Haglund
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

5.  Long-term oncologic and functional outcome in pleomorphic adenomas of the submandibular gland.

Authors:  Konstantinos Mantsopoulos; Miguel Goncalves; Mirco Schapher; Heinrich Iro
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-16

6.  Endoscope-assisted resection of nonneoplastic space-occupying lesion in oral and maxillofacial areas.

Authors:  Yanan Li; Runqi Xue; Qingguo Lai; Bingbing Xu; Kuifeng Yuan; Xiaopeng Tang; Jiangbo Ci; Shaolong Sun; Zhichao Zhang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

7.  Parotid tumours: clinical and oncologic outcomes after microscope-assisted parotidectomy with intraoperative nerve monitoring.

Authors:  F Carta; N Chuchueva; C Gerosa; S Sionis; R A Caria; R Puxeddu
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

Review 8.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

9.  Recurrent Parotid Pleomorphic Adenomas: Our Clinical Experience.

Authors:  Özgür Kümüş; Ahmet Ömer İkiz; Sülen Sarıoğlu; Taner Kemal Erdağ
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-09-01

10.  Comparative Study of Qualitative and Quantitative Analyses of Contrast-Enhanced Ultrasound and the Diagnostic Value of B-Mode and Color Doppler for Common Benign Tumors in the Parotid Gland.

Authors:  Meiying Yan; Dong Xu; Liyu Chen; Lingyan Zhou
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.